Literature DB >> 25325362

Nobiletin protects dopaminergic neurons in the 1-methyl-4-phenylpyridinium-treated rat model of Parkinson's disease.

Kyoung Hoon Jeong1, Min-Tae Jeon, Heung Deok Kim, Un Ju Jung, Min Cheol Jang, Jin Woo Chu, Seung Jun Yang, Il Yoon Choi, Myung-Sook Choi, Sang Ryong Kim.   

Abstract

This study investigated the effect of nobiletin, a flavonoid found in citrus fruits, on the degeneration of dopaminergic (DA) neurons in a neurotoxin model of Parkinson's disease (PD). 1-Methyl-4-phenylpyridinium (MPP(+)) was unilaterally injected into the median forebrain bundle of rat brains (to generate a neurotoxin model of PD) with or without daily intraperitoneal injection of nobiletin. Our results showed that nobiletin treatment at 10 mg/kg bw, but not at 1 or 20 mg/kg bw, significantly protected DA neurons in the substantia nigra (SN) of MPP(+)-treated rats. In parallel to the neuroprotection, nobiletin treatment at 10 mg/kg inhibited microglial activation and preserved the expression of the glial cell line-derived neurotrophic factor, which is a therapeutic agent against PD, in the SN. These results suggest that the proper supplementation with nobiletin may protect against the neurodegeneration involved in PD.

Entities:  

Keywords:  GDNF; MPP+; dopaminergic neuron; microglia; neuroprotection; nobiletin

Mesh:

Substances:

Year:  2014        PMID: 25325362     DOI: 10.1089/jmf.2014.3241

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  12 in total

1.  Nobiletin prevents amyloid β1-40-induced cognitive impairment via inhibition of neuroinflammation and oxidative/nitrosative stress.

Authors:  Reihaneh Ghasemi-Tarie; Zahra Kiasalari; Marzieh Fakour; Maryam Khorasani; Sedigheh Keshtkar; Tourandokht Baluchnejadmojarad; Mehrdad Roghani
Journal:  Metab Brain Dis       Date:  2022-03-16       Impact factor: 3.655

2.  Inhibition of microglial activation and induction of neurotrophic factors by flavonoids: a potential therapeutic strategy against Parkinson's disease.

Authors:  Sang Ryong Kim
Journal:  Neural Regen Res       Date:  2015-03       Impact factor: 5.135

Review 3.  The Multifunctional Effects of Nobiletin and Its Metabolites In Vivo and In Vitro.

Authors:  Hao Huang; Linfu Li; Weimei Shi; Hai Liu; Jianqiong Yang; Xiaoliang Yuan; Longhuo Wu
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-27       Impact factor: 2.629

Review 4.  Polyphenols in Parkinson's Disease: A Systematic Review of In Vivo Studies.

Authors:  Małgorzata Kujawska; Jadwiga Jodynis-Liebert
Journal:  Nutrients       Date:  2018-05-19       Impact factor: 5.717

Review 5.  Neurodegenerative Diseases: Might Citrus Flavonoids Play a Protective Role?

Authors:  Santa Cirmi; Nadia Ferlazzo; Giovanni E Lombardo; Elvira Ventura-Spagnolo; Sebastiano Gangemi; Gioacchino Calapai; Michele Navarra
Journal:  Molecules       Date:  2016-09-30       Impact factor: 4.411

Review 6.  Beneficial Effects of Citrus-Derived Polymethoxylated Flavones for Central Nervous System Disorders.

Authors:  Kentaro Matsuzaki; Yasushi Ohizumi
Journal:  Nutrients       Date:  2021-01-04       Impact factor: 5.717

Review 7.  Molecular regulation of brain metabolism underlying circadian epilepsy.

Authors:  Felix Chan; Judy Liu
Journal:  Epilepsia       Date:  2021-01-04       Impact factor: 5.864

8.  Neuroprotective Activities of Crossyne flava Bulbs and Amaryllidaceae Alkaloids: Implications for Parkinson's Disease.

Authors:  Sylvester I Omoruyi; Abobaker S Ibrakaw; Okobi E Ekpo; James S Boatwright; Christopher N Cupido; Ahmed A Hussein
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

Review 9.  Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease models.

Authors:  Palanivel Ganesan; Hyun-Myung Ko; In-Su Kim; Dong-Kug Choi
Journal:  Int J Nanomedicine       Date:  2015-10-29

10.  Naringin as a beneficial natural product against degeneration of the nigrostriatal dopaminergic projection in the adult brain.

Authors:  Sang Ryong Kim
Journal:  Neural Regen Res       Date:  2017-08       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.